New Paper Alert: Hepatocellular Carcinoma - Stereotactic Body Radiotherapy vs Sorafenib Alone in the NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial - JAMA Oncology - OncoDaily New paper alert on Phase 3 RCT comparing SBRT plus Sorafenib to Sorafenib alone in treating locally advanced hepatocellular carcinoma.

New Paper Alert: Hepatocellular Carcinoma – Stereotactic Body Radiotherapy vs Sorafenib Alone in the NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial – JAMA Oncology

oncodaily.com/library/new-...

#AdvancedHCC #AdvancedHepatocellularCarcinoma #HCC #NewPaperAlert #SBRT #Sorafenib #Medicine